TrialCritical care medicine2014

The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.

Panagis Galiatsatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.